Milestone payment to Evotec expected upon first dosing of first study participant in early 2026 HAMBURG, DE / ACCESS Newswire / December 4, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, SDAX/TecDAX, ...
Q4 2025 earnings call recap: lonvo-z Phase III timeline, MAGNITUDE-2 FDA hold lifted, cash runway and launch plans—read now.
HAMBURG, DE / ACCESS Newswire / December 4, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) today announced that its partner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results